{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:48:47Z","timestamp":1789026527499,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","heartfailure.onlinejacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jchf.2017.10.006","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T17:39:20Z","timestamp":1519925960000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Clinical Characteristics and Outcome of\u00a0Methamphetamine-Associated Pulmonary Arterial Hypertension and\u00a0Dilated Cardiomyopathy"],"prefix":"10.1016","volume":"6","author":[{"given":"Susan X.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gohil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2017.10.006_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0024-3205(03)00260-1","article-title":"Heart disease, methamphetamine and AIDS","volume":"73","author":"Yu","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.jchf.2017.10.006_bib2","first-page":"8","article-title":"Acute coronary syndrome and crystal methamphetamine use: a case series","volume":"63","author":"Wijetunga","year":"2004","journal-title":"Hawaii Med J"},{"key":"10.1016\/j.jchf.2017.10.006_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0002-8703(88)90820-4","article-title":"Myocardial injury-associated with polysubstance abuse","volume":"115","author":"Lam","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2017.10.006_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.hdx.0000080713.09303.a6","article-title":"Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine","volume":"5","author":"Frishman","year":"2003","journal-title":"Heart Dis"},{"key":"10.1016\/j.jchf.2017.10.006_bib5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.130.6.1657","article-title":"Is methamphetamine use-associated with idiopathic pulmonary arterial hypertension?","volume":"130","author":"Chin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jchf.2017.10.006_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjmed.2006.01.024","article-title":"The association of methamphetamine use and cardiomyopathy in young patients","volume":"120","author":"Yeo","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2017.10.006_bib7","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1081\/CLT-120026521","article-title":"Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?","volume":"41","author":"Wijetunga","year":"2003","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.jchf.2017.10.006_bib8","first-page":"435","article-title":"Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy","volume":"5","author":"Sch\u00fcrer","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2017.10.006_bib9","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/clc.20367","article-title":"A\u00a0comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse","volume":"32","author":"Ito","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jchf.2017.10.006_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/imj.13050","article-title":"Methamphetamine-associated cardiomyopathy: patterns and predictors of recovery","volume":"46","author":"Voskoboinik","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.jchf.2017.10.006_bib11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1360-0443.2007.01874.x","article-title":"Methamphetamine and cardiovascular pathology: a review of the evidence","volume":"102","author":"Kaye","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jchf.2017.10.006_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/clc.22195","article-title":"Methamphetamine-associated cardiomyopathy","volume":"36","author":"Won","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jchf.2017.10.006_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjmed.2006.01.024","article-title":"The Association of methamphetamine use and cardiomyopathy in young patients","volume":"120","author":"Khung-Keong Yeo","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2017.10.006_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12012-016-9385-8","article-title":"Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC)","volume":"17","author":"Jafari Giv","year":"2017","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jchf.2017.10.006_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations\u00a0for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2017.10.006_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2017.10.006_bib17","first-page":"1764","article-title":"[ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment]","volume":"141","author":"Opitz","year":"2016","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jchf.2017.10.006_bib18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.10.006_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.publhealth.012809.103600","article-title":"The methamphetamine problem in the United States","volume":"31","author":"Gonzales","year":"2010","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jchf.2017.10.006_bib20","unstructured":"U.S. Census Bureau. QuickFacts selected: Santa Clara County, California. Available at: https:\/\/www.census.gov\/quickfacts\/fact\/table\/santaclaracountycalifornia\/PST045216. Accessed September 28, 2017."},{"key":"10.1016\/j.jchf.2017.10.006_bib21","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1378\/chest.108.4.1140","article-title":"Stimulant-induced pulmonary toxicity","volume":"108","author":"Albertson","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.jchf.2017.10.006_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.104.2.614","article-title":"Pulmonary hypertension-associated with long-term inhalation of \u201ccrank\u201d methamphetamine","volume":"104","author":"Schaiberger","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.jchf.2017.10.006_bib23","doi-asserted-by":"crossref","first-page":"L252","DOI":"10.1152\/ajplung.00453.2016","article-title":"Reduced carboxylesterase 1 is-associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension","volume":"313","author":"Orcholski","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jchf.2017.10.006_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09595230801923702","article-title":"Major physical and psychological harms of methamphetamine use","volume":"27","author":"Darke","year":"2008","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.jchf.2017.10.006_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0009-9236(95)90041-1","article-title":"Methamphetamine and ethanol interactions in humans","volume":"57","author":"Mendelson","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jchf.2017.10.006_bib26","first-page":"214","article-title":"Methamphetamine and the expanding complications of amphetamines","volume":"170","author":"Albertson","year":"1999","journal-title":"West J Med"},{"key":"10.1016\/j.jchf.2017.10.006_bib27","series-title":"New research on methamphetamine abuse","author":"Toolaney","year":"2007"},{"key":"10.1016\/j.jchf.2017.10.006_bib28","series-title":"Mortality amongst illicit drug users: epidemiology, causes and intervention","author":"Darke","year":"2006"},{"key":"10.1016\/j.jchf.2017.10.006_bib29","unstructured":"Tobacco Use in Santa Clara County\u2014tobacco-use. Available at: https:\/\/www.sccgov.org\/sites\/phd\/hi\/hd\/Documents\/tobacco-reports\/tobacco-use.pdf. Accessed September 28, 2017."},{"key":"10.1016\/j.jchf.2017.10.006_bib30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","article-title":"Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension","volume":"100","author":"Rothman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.10.006_bib31","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1378\/chest.07-0235","article-title":"Methamphetamine and idiopathic pulmonary arterial hypertension: role of the serotonin transporter","volume":"132","author":"Rothman","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jchf.2017.10.006_bib32","series-title":"Cardiotoxicity-Associated With Methamphetamine Use and Signs of Cardiovascular Pathology Among Methamphetamine Users","author":"Kaye","year":"2005"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917306923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917306923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T13:58:01Z","timestamp":1551621481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177917306923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213177917306923"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2017.10.006","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics and Outcome of\u00a0Methamphetamine-Associated Pulmonary Arterial Hypertension and\u00a0Dilated Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}